Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Change in Restricted Stock Unit

The following table summarizes information about the changes in restricted stock units for the years ended December 31, 2024, 2023 and 2022, respectively.

	For the year ended					For the year ended					For the year ended
	December 31, 2024					December 31, 2023					December 31, 2022
	Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value
Balance at beginning of period		53,817		$	37.04		39,657		$	47.83		22,597		$	48.91
Grants		45,064			34.37		33,294			29.53		24,833			47.19
Vesting		(24,075	)		40.35		(14,553	)		48.00		(7,425	)		48.91
Forfeited/expired		(3,150	)		34.53		(4,581	)		41.09		(348	)		48.91
Balance at end of period		71,656		$	34.36		53,817		$	37.04		39,657		$	47.83

Schedule of Change in Performance Stock Units

The following table summarizes information about the changes in PSUs as of and for the years ended December 31, 2024, 2023 and 2022, respectively.

	For the year ended					For the year ended					For the year ended
	December 31, 2024					December 31, 2023					December 31, 2022
	Performance-Based Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Performance-Based Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value		Performance-Based Restricted Stock Units Outstanding			Weighted Average Grant Date Fair Value
Balance at beginning of period		75,227		$	40.24		47,082		$	48.00		22,597		$	48.91
Grants		45,064			34.37		33,294			29.53		24,833			47.19
Vesting		(20,532	)		48.91		—			—		—			—
Forfeited/expired		(3,553	)		35.14		(5,149	)		41.95		(348	)		48.91
Balance at end of period		96,206		$	35.83		75,227		$	40.24		47,082		$	48.00

Schedule of Analysis of Stock Option Activity

An analysis of stock option activity for the year ended December 31, 2024 is presented in the table and narrative below:

	Shares			Weighted- Average Ex. Price		Weighted- Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value ($000)
Outstanding, beginning of year		1,552,249		$	30.45
Granted		270,495			34.37
Exercised		(163,521	)		20.28
Cancelled		(73,797	)		34.75
Outstanding, end of year		1,585,426			31.96		5.87	$	10,894
Exercisable at end of year		919,010		$	28.61		4.12	$	9,081

Schedule of Information Concerning Outstanding and Vested Stock Options

The following table summarizes information concerning outstanding and vested stock options as of December 31, 2024:

Exercise Price		Number Outstanding		Remaining Contracted Life (Years)		Number Vested
$	16.95		163,492		0.8		136,492
$	21.18		315,397		2.4		315,397
$	29.70		258,180		4.5		201,070
$	34.55		6,700		5.1		3,900
$	48.91		168,271		6.6		102,469
$	47.19		201,918		7.6		82,856
$	29.53		229,312		8.6		76,826
$	34.37		269,156		9.6		—

Summary of Vested and Unvested Restricted Stock Outstanding

The following table summarizes information about vested and unvested restricted stock.

	For the year ended					For the year ended					For the year ended
	December 31, 2024					December 31, 2023					December 31, 2022
	Restricted Stock Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Outstanding			Weighted Average Grant Date Fair Value		Restricted Stock Outstanding			Weighted Average Grant Date Fair Value
Balance at beginning of period		25,190		$	27.79		24,813		$	36.21		46,598		$	35.75
Grants		24,348			30.91		25,190			27.79		15,425			40.89
Vesting		(25,190	)		27.79		(23,708	)		36.40		(37,010	)		37.61
Forfeited/expired		—			—		(1,105	)		29.70		(200	)		29.70
Balance at end of period		24,348		$	30.91		25,190		$	27.79		24,813		$	36.21